Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Abbott boosts pipeline with biotech acquisition

March 10, 2010 Research and Development, Sales and Marketing Abbott, Facet Biotech, daclizumab, volociximab

Abbott is to acquire US company Facet Biotech in a $450 million deal that will boost its oncology and immunology …
News
Worker protest

GSK Italy workers protest site closure

March 10, 2010 Research and Development GlaxoSmithKline, Italy, job cuts

Workers at a GlaxoSmithKline R&D facility in Verona, Italy, have taken to the streets to protest a decision to close …
News

Recentin disappoints in colorectal cancer

March 9, 2010 Research and Development AZ, Cancer, Recentin, colorectal cancer

AstraZeneca’s developmental oncology drug Recentin has failed to meet its primary endpoint in a phase II/III study. The once-daily oral …
News

Pfizer and King’s to collaborate on pain research

March 9, 2010 Research and Development King's, Pfizer, UK

Pfizer has partnered with King’s College London to create an open innovation laboratory for pain research.The project will include a …
News
Rheumatoid arthritis

Roche halts ocrelizumab trials

March 8, 2010 Research and Development RoActemra, ocrelizumab, rheumatoid arthritis

The future of Roche and Biogen Idec’s rheumatoid arthritis drug ocrelizumab has been thrown into doubt after the manufacturers decided …
News
Blood clot

Phase III success for apixaban

March 5, 2010 Research and Development BMS, Pfizer, VTE, apixaban

Pfizer and Bristol-Myers Squibb’s apixaban has shown promising results in a late-stage head-to-head trial with Sanofi-Aventis’ Lovenox. The oral anti-coagulant …
News

Pfizer suffers Alzheimer’s setback

March 4, 2010 Research and Development Alzheimer's, Medivation, Pfizer

Pfizer has suffered a big setback with the oral Alzheimer’s disease treatment it is developing with biotech outfit Medivation. Investigational …
News
Andreotti

Lamberto Andreotti new head of Bristol-Myers Squibb

March 4, 2010 Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing

Bristol-Myers Squibb has appointed Lamberto Andreotti its new chief executive with effect from 4 May, succeeding James Cornelius who will …
Appointment

Stem cell therapy helps diabetes limb problems

March 3, 2010 Research and Development ReNeuron, diabetes, stem cell

Stem cell therapy aimed at restoring blood flow to damaged limbs in people with diabetes has shown promise, according to UK …
News

Funds keep Archimedes Pharma buoyant

March 3, 2010 Research and Development Archimedes, funding

Archimedes Pharma has completed the biggest fundraising by a private European biotech in 15 years by securing £65 million. The …
News

UK hit hard as AstraZeneca reveals R&D cuts

March 3, 2010 Research and Development AstraZeneca, job cuts

Nearly 3,500 R&D jobs will be affected at AstraZeneca in the coming months as the pharmaceutical giant exits discovery research …
News

Kinex Pharmaceuticals appoints Rudolf Kwan

March 2, 2010 Research and Development Kinex Pharmaceuticals, appointment, research and development

Dr Rudolf Kwan has joined Buffalo, US-based  Kinex Pharmaceuticals as chief medical officer. He will be responsible for the design …
Appointment

Clinical research news in brief

March 2, 2010 Research and Development Community Research, Evotec, FDA, INC Research, Kendle, Parexel

A round-up of recent developments in the clinical research arena includes proposals from the FDA on reporting falsified trials, Kendle’s …
News

Quotient Bioresearch Presents Comprehensive Drug Development Capabilities via New Company Website

March 1, 2010 Research and Development

Quotient Bioresearch partners its clients with a unique offering of leading-edge technologies and services for all stages of early drug …
News
Press release
Merck KGaA

Merck KGaA invests in bioresearch and bioproduction

March 1, 2010 Manufacturing and Production, Research and Development Biochemistry, Merck KGaA, Merck Serono, Millipore, laboratory services

Merck KGaA has bought US life sciences company Millipore Corporation in a $7.2 billion deal to expand its chemicals business. …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026